Idiopathic pulmonary fibrosis (IPF) is an age-related disease featuring progressive lung scarring. To elucidate the molecular basis of IPF, we performed exome sequencing of familial kindreds with pulmonary fibrosis. Gene burden analysis comparing 78 European cases and 2,816 controls implicated PARN, an exoribonuclease with no previous connection to telomere biology or disease, with five new heterozygous damaging mutations in unrelated cases and none in controls (P = 1.3 × 10 −8 ); mutations were shared by all affected relatives (odds in favor of linkage = 4,096:1). RTEL1, an established locus for dyskeratosis congenita, harbored significantly more new damaging and missense variants at conserved residues in cases than in controls (P = 1.6 × 10 −6 ). PARN and RTEL1 mutation carriers had shortened leukocyte telomere lengths, and we observed epigenetic inheritance of short telomeres in family members. Together, these genes explain ~7% of familial pulmonary fibrosis and strengthen the link between lung fibrosis and telomere dysfunction.
Idiopathic pulmonary fibrosis (IPF) is an age-related disease featuring progressive lung scarring. To elucidate the molecular basis of IPF, we performed exome sequencing of familial kindreds with pulmonary fibrosis. Gene burden analysis comparing 78 European cases and 2,816 controls implicated PARN, an exoribonuclease with no previous connection to telomere biology or disease, with five new heterozygous damaging mutations in unrelated cases and none in controls (P = 1.3 × 10 −8 ); mutations were shared by all affected relatives (odds in favor of linkage = 4,096:1). RTEL1, an established locus for dyskeratosis congenita, harbored significantly more new damaging and missense variants at conserved residues in cases than in controls (P = 1.6 × 10 −6 ). PARN and RTEL1 mutation carriers had shortened leukocyte telomere lengths, and we observed epigenetic inheritance of short telomeres in family members. Together, these genes explain ~7% of familial pulmonary fibrosis and strengthen the link between lung fibrosis and telomere dysfunction.
IPF is the prototype of adult-onset interstitial lung disease that preferentially affects males and smokers 1, 2 . The disease is progressive, with a life expectancy of 2-3 years after diagnosis. The genetic basis of IPF is incompletely understood. Common variants explain a small fraction of disease risk, including loci near MUC5B and TERT, which encodes the protein component of telomerase 3 . Rare coding mutations in TERT are found in ~15% of familial kindreds with pulmonary fibrosis and show autosomal dominant transmission with incomplete penetrance [4] [5] [6] . Less frequently, rare mutations of large effect are found in the genes encoding the human telomerase RNA component (TERC) 4, 5 , dyskerin (DKC1) 7, 8 and surfactant proteins (SFTPC and SFTPA2) [9] [10] [11] . Some probands of familial kindreds with pulmonary fibrosis have short telomere lengths that are unexplained by mutations affecting telomerase 12 , suggesting a role for other genes involved in telomere maintenance.
We performed whole-exome sequencing and analysis on genomic DNA samples from 99 probands with familial pulmonary fibrosis of unknown genetic cause (Online Methods). Principal-component analysis of the genotypes from the exome data showed that 79 probands Observed (-log P)
Expected (-log P) Expected (-log P) Figure 1 Quantile-quantile plot of observed versus expected P values comparing the burden of new variants in protein-coding genes in familial pulmonary fibrosis cases and controls. New variants in 78 European probands with pulmonary fibrosis and 2,816 European controls were identified, and their frequencies were compared by Fisher's exact test. The distribution of observed P values for each gene was compared to the distribution of expected P values. (a) Analysis of new variants that are either damaging or missense alterations at positions that are highly conserved across the phylogeny. (b) Analysis of new damaging variants. The distribution of observed P values generally follows the expected distribution for damaging plus missense variants at conserved residues, whereas, for damaging mutations only, many P values are lower than expected owing to a paucity of variants. The damaging plus missense set shows two genes (RTEL1 and PARN) with P values at or near genome-wide significance; the damaging variant set shows one gene, PARN, with an observed P value well outside the expected distribution.
l e t t e r s npg clustered with HapMap subjects of European ancestry, whereas 19 and 1 clustered with subjects of Mexican and African-American ancestry, respectively. Sequencing and analysis of control subjects on the same platforms led to the identification of 2,816 controls of European ancestry (Supplementary Fig. 1 ). In cases and controls, 93.3% and 95.3%, respectively, of all targeted bases had eight or more independent reads (Supplementary Tables 1 and 2) . With a population disease frequency for familial pulmonary fibrosis of <1 per 100,000 individuals 13 , we expected dominant alleles of large effect to be individually very rare in the population. To enrich for variants that were likely to alter the function of the encoded proteins, we identified damaging variants (premature termination, frameshift and splice site) and variants that altered positions that were highly conserved across orthologs. We compared the burdens of damaging variants and damaging plus missense variants at conserved residues in protein-coding genes; the analysis was limited to new singletons in cases and controls that were not found in the National Heart, Lung, and Blood Institute (NHLBI) Exome Sequencing Project (ESP) and 1000 Genomes Project databases (Supplementary Table 3 ). There was a mean of 49.0 new variants per subject in cases and 50.3 new variants per subject in controls. Because subjects in the NHLBI ESP database included individuals with various cardiopulmonary diseases, as a check to ensure that we did not exclude disease-related variants, we also performed the analyses considering all alleles with minor allele frequency (MAF) <0.1% (Supplementary Table 4) . Quantile-quantile plots showed good matching of expected and observed P values for missense and damaging variants, whereas observed P values for damaging singletons were generally below the expected values owing to the paucity of such variants (Fig. 1) . Two genes surpassed the threshold for genome-wide significance in these analyses (P < 2.4 × 10 −6 after accounting for the examination of 21,000 genes); no other gene had P < 1 × 10 −4 ( Fig. 1 , Table 1 and Supplementary  Tables 3-5) . PARN (encoding polyadenylation-specific ribonuclease deadenylation nuclease), a 3′ exoribonuclease that has not previously been implicated in disease or telomere maintenance, had six damaging variants in probands and zero in controls (P = 3.8 × 10 −10 ); we confirmed all of the variants by Sanger sequencing, and all were absent in the dbSNP, 1000 Genomes Project and NHLBI cohorts ( Table 2 ). We subsequently found that two of the PARN variants were identical by descent (IBD) from a recent common ancestor. Retrospectively, when considering the presence of only 5 independent new damaging mutations in PARN in 78 (not 79) unrelated cases, the result remained highly significant (P = 1.3 × 10 −8 ). The significance of this result was further supported by the absence of damaging mutations in PARN among the 6,500 subjects (including 4,300 subjects of European ancestry) comprising the NHLBI controls (P = 1.7 × 10 −9 in European cases versus controls). We found an additional new missense variant (encoding p.Lys421Arg) in a proband of European ancestry. PARN is among the 20% of genes with the lowest prevalence of rare variants that are likely to disrupt normal function (mutation-intolerant genes) 14 , consistent with the identified variants causing haploinsufficiency.
Two probands not known to be related (F349 and F373) shared the same rare PARN variant altering the canonical splice acceptor site of intron 4 (AG>GG; c.246-2A>G (IVS4 -2A>G)). Tracing birth and death records for both kindreds established that these two individuals had a great grandmother in common (individual II.2, Fig. 2 ). Kinship analysis using the Beagle program showed that the probands shared an estimated 6.4% of their genomes. The IVS4 -2A>G variant mapped to a segment of identity by descent that was ~18 Mb in length, supporting the relatedness of these two individuals.
As an independent test of the relevance of these PARN variants, we compared their segregation to that of pulmonary fibrosis in the extended kindreds of each index case. Among seven relatives with pulmonary fibrosis in whom mutation status was assessed None of the listed variants were found in dbSNP (version 138), the 1000 Genomes Project database (phase 2) or the NHLBI Exome Variant Server database available from ESP (ESP6500SI-V2).
a The positions of the DNA and protein variants are described using PARN NM_002582.3 (variant 1) and RTEL1 NM_001283009.1 (variant 3). b The same mutation was found in two different probands, who are distantly related to each other, as shown in Figure 2 . l e t t e r s npg l e t t e r s either by direct sequencing or imputation of obligate carriers, all inherited the new PARN variants identified in their respective probands, an event that is highly unlikely to have occurred by chance (logarithm of odds (LOD) score of 3.6; backwards odds of 4,096:1 in favor of linkage of rare PARN variants in affected-only analysis). Because of the rarity of the identified mutant alleles, the LOD scores were only modestly changed by increased estimates of mutant allele frequency. The mutations were also shared by five relatives identified as having significant lung disease who did not meet current criteria for a diagnosis of fibrosing lung disease (Supplementary Table 6 ). There were also nine clinically unaffected subjects who harbored the rare variants found in the probands, indicating incomplete penetrance. All five loss-of-function PARN variants affected residues within the CAF1 ribonuclease domain, which is conserved through yeast and makes up a critical component of a cytoplasmic deadenylase (Fig. 2g) . A lymphoblastic cell line (LCL) derived from the proband with the p.Gln177* alteration demonstrated greater expression of the wild-type allele than of the mutant allele ( Supplementary Fig. 2a) , and PARN protein expression was reduced in six independent LCLs representing three different loss-of-function alterations (p.Gln177* and IVS4 and IVS6 splice-site alterations) (Supplementary Fig. 2b ). There was 
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(1) were found to be related through a distant ancestor (II.2). The PARN cDNA mutation or predicted amino acid change is listed above each family. Individuals with pulmonary fibrosis or an unclassified lung disease are indicated by pink and blue symbols, respectively. Unfilled symbols represent individuals with no self-reported lung disease. Arrows indicate the probands. Numbers in parentheses indicate individuals for whom no DNA sample was available. The presence or absence of a mutation is indicated by a plus or minus sign, respectively. When the mutation was inferred on the basis of location in the pedigree, the plus sign appears in parentheses. Age (in years) at the time of blood draw or death is indicated to the upper right of each symbol. (g) Schematic of the functional domains of PARN with the positions of the alterations indicated by arrows. Conserved protein domains include the CAF1 ribonuclease domain (blue), the R3H domain that binds single-stranded nucleic acids (pink) and the RNA-recognition domain (RRM; green). npg l e t t e r s no apparent decrease in PARN protein levels in LCLs derived from subjects heterozygous for the variant encoding p.Lys421Arg.
The other gene with a significant mutation burden was RTEL1 (encoding regulator of telomere elongation helicase 1), which is known to have a role in telomere maintenance. Mutations in RTEL1 have recently been shown to cause Hoyeraal-Hreidarsson syndrome, a severe variant of dyskeratosis congenita presenting in childhood and associated with telomere shortening [15] [16] [17] [18] [19] . Affected subjects typically have biallelic mutations; however, heterozygotes have sometimes been noted to display disease manifestations.
We found 5 new heterozygous variants in RTEL1 (NM_001283009.1) in probands with pulmonary fibrosis (two damaging and three missense variants at highly conserved positions), whereas we observed 4 singletons among 2,816 control subjects (P = 1.6 × 10 −6 ; Fig. 3 and Table 2 ). Similarly, in the NHLBI cohort, there were 6 singleton variants in RTEL1 among the 4,300 subjects of European ancestry (2 damaging and 4 missense variants at conserved residues; P = 7.1 × 10 −7 for comparison with cases). RTEL1 ranks among the 2% most mutation-intolerant genes in the genome 14 , consistent with phenotypic effects arising from heterozygous mutations. The RTEL1 protein contains an N-terminal helicase domain that preserves telomere length during replication by unwinding the repetitive telomere TTAGGG sequences, which are organized in G-quartet secondary structures, and by disassembling the lasso-like T loops at the ends of telomeres 20 . Two rare RTEL1 variants were predicted to be loss-of-function alleles; the frameshift mutation (encoding p.Gly201Glufs) and the premature truncation variant (p.Gln693*) were predicted to interrupt the highly conserved RAD3-related DNA helicase domain (Fig. 3f) . Three missense alleles found in probands affected highly conserved amino acids (Fig. 3g) . As seen with PARN, all relatives diagnosed with pulmonary fibrosis in whom mutation status could be assessed inherited the same rare RTEL1 variant found in probands (backward odds of 128:1 in favor of linkage). Five mutation carriers were reported to be free of pulmonary disease, indicative of incomplete penetrance. Pulmonary fibrosis has previously been reported in only one case of severe dyskeratosis congenita due to biallelic RTEL1 mutations 16 , and none of the heterozygous RTEL1 mutation carriers described here demonstrated the mucocutaneous features of dyskeratosis congenita (Supplementary Table 6 ). The new mutations thus expand the clinical phenotype associated with RTEL1 mutations. While this manuscript was under review, J.D. Cogan and colleagues described nine rare RTEL1 variants in kindreds with pulmonary fibrosis 21 . This finding provides further support for the conclusion that heterozygous RTEL1 mutations are associated with pulmonary fibrosis in the absence of dyskeratosis congenita mucocutaneous features.
The telomere lengths in genomic DNA isolated from the circulating leukocytes of probands with PARN and RTEL1 mutations were shorter than the telomere lengths in corresponding cells from their unrelated spouses (P < 0.001 for both genes) as determined by terminal restriction fragment length (TRFL) analysis (Fig. 4a-c) . The probands with PARN and RTEL1 mutations also demonstrated a higher percentage of short telomere lengths (TRFL < 3 kb) than normal controls (P = 0.003 and 0.001, respectively). We also measured telomere lengths using a quantitative PCR assay 6, 12 . We used estimated regression coefficients from a control cohort 22 to calculate the age-adjusted telomere lengths of each subject. Six of the seven probands with PARN mutations and all five probands with RTEL1 mutations had age-adjusted telomere lengths below the 10th percentile (Fig. 4d) . The proband with the PARN c.751delA mutation (encoding p.Arg251Glufs*14) had telomere lengths in the ~30th percentile. More than half of all mutation carriers studied (24/46) had telomere lengths below the 1st percentile, 65% had lengths below the 10th percentile and nearly all had lengths at or below the 50th percentile. The mean age-adjusted telomere lengths of the PARN and RTEL1 mutation carriers were significantly shorter than those of normal controls (P < 0.001 for both genes; Fig. 4e ). These were also similar to the telomere length measurements of TERT and TERC mutation carriers 22 . The mean telomere lengths of related family members who did not inherit the PARN or RTEL1 mutations were shorter than those of unrelated individuals (spouses) but longer than those of the PARN or RTEL1 mutation carriers (Fig. 4e) . 
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These findings are consistent with the genetic and epigenetic inheritance of telomere lengths, which has been observed in kindreds carrying TERT mutations 6 . These studies implicate rare heterozygous loss-of-function variants in PARN and RTEL1 in pulmonary fibrosis associated with shortened telomeres. The results show a significantly increased burden of these variants in cases in comparison to two independent control cohorts. In addition, these mutations have large effects on disease risk, as indicated by the high odds ratios for association of these rare variants with disease. Although no other genes in this study were significant at genome-wide thresholds, we cannot exclude effects from variants in other genes in small numbers of kindreds. This study demonstrates the usefulness of exome sequencing of probands in discovering new disease-associated loci of large effect, despite complexities such as locus heterogeneity, reduced penetrance and late onset of disease.
We found new damaging or missense PARN and RTEL1 variants at conserved positions in 12% of the probands studied. With extrapolation to our complete cohort of familial kindreds with pulmonary fibrosis that includes subjects with mutations in known associated genes, PARN and RTEL1 mutations are found in at least 4% and 3% of probands, respectively. These frequencies are intermediate between those of TERT mutations (16%) and mutations in SFTPC (2%) or SFTPA2 (1%).
To our knowledge, this is the first report of a clinical phenotype associated with heterozygous PARN mutations. PARN has a role in the translational silencing of maternal gene expression through 5′ cap-dependent deadenylation of mRNAs during oocyte maturation and early development 23, 24 . In addition, PARN has been shown to be involved in the maturation of Argonaute2-cleaved precursor microRNAs 25 and H/ACA-box small nucleolar RNAs (snoRNAs) 26 . The mechanism linking PARN mutation to telomere shortening is currently unclear. However, H/ACA-box snoRNAs are known to associate with four evolutionarily conserved and essential proteinsdyskerin, GAR1, NHP2 and NOP10-and mutations in genes encoding three of these proteins cause dyskeratosis congenita [27] [28] [29] . We speculate that haploinsufficiency for PARN may lead to telomere shortening through dysregulation of H/ACA-box snoRNAs or the RNA component of human telomerase (TERC), which itself contains an H/ACA domain.
Short telomere lengths are disproportionately represented in individuals with sporadic IPF 12, 30 and are associated with worse survival 22 . The identification of two new genes contributing to this trait strengthens the link between telomere attrition and lung fibrosis and describes a new gene required for telomere maintenance.
URLs. ClustalW, http://www.ebi.ac.uk/clustalw/; ImageJ software, http://imagej.nih.gov/ij/.
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Methods and any associated references are available in the online version of the paper. shown as open green and blue circles, respectively. Open black circles represent unrelated normal controls. NS, not significant. In d and e, the mean telomere length is indicated by the black bar. The black dotted line shows the median telomere length of an independent control group; approximate age-adjusted prediction bands (percentiles, blue dotted lines) were previously calculated from a linear regression model using the controls.
npg l e t t e r s Genomic DNA was isolated from circulating leukocytes using AutoPure (Qiagen) according to the manufacturer's instructions. Genomic DNA was selected from a cohort of 185 kindreds that were screened to exclude those with rare variants in TERT (n = 30), TERC (n = 5), SFTPC (n = 2) and SFTPA2 (n = 2). Variants in these four genes were identified by Sanger sequencing either by research investigation 5, 6, 11 or by CLIA-certified companies (GeneDx, Ambry Genetics, Advanced Diagnostics Laboratory at Children's Medical Center in Dallas, Texas, USA).
Lymphocytes were isolated from blood drawn in Acid Citrate Dextrose tubes using lymphocyte separation medium (MP Biomedicals). EpsteinBarr virus (EBV)-transformed LCLs were established by incubating ~1 × 10 6 lymphocytes, either freshly isolated or previously stored in liquid nitrogen, with EBV shed from a marmoset cell line (B95-8, American Type Culture Collection) and the mitogen phytohemagglutinin. The cell lines were cultured in RPMI 1640 (HyClone) supplemented with 15% FBS, 2 mM l-glutamine, 1 mM pyruvate, penicillin (100 U/ml) and streptomycin (100 µg/ml), fed twice weekly and expanded to a suspension culture volume of at least 50 ml before storage and use.
Whole-exome sequencing and analysis. Targeted capture was performed using the NimbleGen/Roche Exome V2.0 reagent followed by 74-bp end sequencing on the Illumina platform. Sequence quality statistics for cases and controls across the whole exome are shown in Supplementary Sequences were aligned to the reference genome, and variants were called using SAMtools as previously described 32 and the Genome Analysis Toolkit (GATK) HaplotypeCaller. Controls included the unaffected parents of offspring with autism and congenital heart disease 32-34 and unaffected subjects sequenced for a study of cardiovascular disease (W.J., M. Choi and R.P.L., unpublished data). All cases and 2,334 of the 2,816 controls were sequenced by the Yale Center for Genome Analysis; the remaining 482 controls were sequenced at the Cold Spring Harbor Laboratory. All cases and controls (noted as YCGA controls) were sequenced on the same capture-and-sequencing platform and were analyzed using the same algorithms (SAMtools). The variants identified by this pipeline were used in all subsequent analyses. European ancestry in cases and controls was established by principal-component analysis using exome data in combination with data from subjects from the HapMap Consortium 35 . In principal-component analysis of genotypes from exome data, 79 probands and 2,816 controls clustered with HapMap subjects of European ancestry. Kinship analysis was performed using Beagle 36 ; overlapping shared tracks were merged to estimate the maximum length of a shared haplotype. After it was determined that 2 of the probands were distantly related to each other (Fig. 2a) , only 78 unrelated probands were used in gene burden analyses against ancestrymatched controls. The frequency of the variants was evaluated using exome data deposited in the NHLBI Exome Variant Server (ESP), the 1000 Genomes Project and the Yale exome database (a reference database that is distinct from the Yale controls described above), which includes ~20,000 independent alleles. Gene burden analysis was performed comparing the number of new damaging variants (nonsense, frameshift and splice-site mutations), the number of new missense variants involving highly conserved residues (found in all or all but 1 ortholog among 47 species with genome sequencing) and the number of variants with MAF <0.1% in each gene for cases and controls. Gene burden analyses using the allele as the unit of analysis are reported in Table 1 and Supplementary Tables 3 and 4 . Results using the individual as the unit of analysis are reported in Supplementary Table 5 . More than 400 new variants called in the Yale data set had confirmation attempted by PCR amplification and Sanger sequencing, with 99.8% confirmed 32, 33, 37 . A second and independent control data set (termed NHLBI controls) was evaluated from exome data deposited in the NHLBI Exome Variant Server (ESP) database. All sequences used in comparative alignment and the positions of amino acid conserved domains were obtained from NCBI. Comparison of homologous sequences was based on a ClustalW-generated alignment using the default settings.
Sanger sequencing of genomic DNA. Direct bidirectional Sanger sequencing of the mutations was performed using an ABI 3700 automated sequencer and BigDye terminator cycle sequencing reagents (Applied Biosystems). PCR conditions and the sequences of the primers used for PARN and RTEL1 are listed in Supplementary Table 7 . Representative Sanger sequence electropherograms are shown in Supplementary Figure 3. Linkage analysis. As each of the new variants was not observed among more than 20,000 independent alleles, we assumed that each was not independently introduced but was inherited IBD through obligate carriers in each pedigree. Affected-only backward LOD scores were calculated as the logarithm of the likelihood ratio (LR) in favor of linkage considering only the affected individuals 38 . Assuming a dominant model in which all affected individuals share one allele IBD and assuming that there are no sporadic cases within a multiplex family, the equation simplifies to:
where r(n) is the relative relationship for each family n. The denominator is the probability that all affected individuals in a kindred share one allele IBD, and it depends on the pedigree structure. For example, the probability that an affected sibling pair shares one allele IBD is 1/2.
RNA analysis and immunoblotting. RNA was isolated from pelleted LCLs using TRIzol (Ambion). After DNase I treatment, first-strand cDNA was generated using random hexamers and the High-Capacity cDNA Reverse Transcription kit (Applied Biosystems). The oligonucleotides used to amplify the 181-nt PARN product were 5′-TGATGAAAAACGTTCACAGG-3′ and 5′-GGTACATGGCTCTAAATCCA-3′. Suspension culture LCLs were pelleted and lysed with CytoBuster protein extraction reagent (EMD Millipore) containing protease inhibitor cocktail (Sigma). Protein concentrations were determined using the BCA assay (Pierce). Equal amounts of cell lysate proteins (10 µg) were added to Laemmli sample buffer with β-mercaptoethanol, separated by 10% SDS-PAGE and transferred to PVDF membranes. Membranes were incubated in blocking buffer (5% dried nonfat milk in TBST (150 mM NaCl, 10 mM Tris, pH 8, 0.1% Tween-20)) for 1 h before overnight incubation at 4 °C with either rabbit polyclonal antibody to PARN (Abcam, ab125185; 1:1,000 dilution) or mouse monoclonal antibody to tubulin (Sigma, T9026; 1:10,000 dilution). Signals were visualized by chemiluminescence (Bio-Rad) after incubation of membranes with horseradish peroxidase (HRP)-conjugated secondary antibody (Cell Signaling Technology). The intensity of each PARN band was quantified using ImageJ software.
Telomere length measurements. Telomere lengths were independently measured by calculating the TRFL as described 39 . The percentage of short telomeres was calculated by computing the percentage of signal below 3 kb normalized by molecular weight. The telomere lengths of genomic DNA specimens isolated from circulating leukocytes were measured using the same quantitative PCR assay we previously described 6, 12, 22 and are reported as the logarithm-transformed relative ratio of telomeres to a single-copy gene (relative T/S). A linear regression model using 201 control participants 12 had previously been used to calculate age-adjusted prediction bands, and the estimated regression coefficients were used to calculate the observed minus expected, or age-adjusted, telomere lengths. 
